CYP3A4 and cancer: Of particular note was the finding that to recover the observed data in cancer patients with moderate RI (CrCL 20 to 39 mL/min), reductions of hepatic CYP3A4 and CYP2C8 expression, which reflect the effects of RI, had to be included in the simulations.